Detalles de la búsqueda
1.
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
Cell
; 185(20): 3705-3719.e14, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179667
2.
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
N Engl J Med
; 386(14): 1327-1338, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35388666
3.
Global distribution and genomic characteristics of carbapenemase-producing Escherichia coli among humans, 2005-2023.
Drug Resist Updat
; 72: 101031, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071860
4.
Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory ompK36 mRNA secondary structure.
Proc Natl Acad Sci U S A
; 119(38): e2203593119, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36095213
5.
Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric Hospital.
Clin Infect Dis
; 78(1): 15-23, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647637
6.
Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
Clin Infect Dis
; 78(1): 27-30, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584360
7.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738153
8.
Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
Am J Transplant
; 24(6): 1046-1056, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342183
9.
Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem.
Antimicrob Agents Chemother
; 68(3): e0154123, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319075
10.
Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-ß-lactamase (blaVIM): infection management and molecular analysis.
Antimicrob Agents Chemother
; 68(5): e0147423, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38602418
11.
Understanding blaNDM-1 gene regulation in CRKP infections: toward novel antimicrobial strategies for hospital-acquired pneumonia.
Mol Med
; 30(1): 29, 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395744
12.
Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Curr Opin Infect Dis
; 37(2): 137-143, 2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179988
13.
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer ß-lactam or ß-lactam/ß-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimen.
J Antimicrob Chemother
; 79(1): 82-95, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962080
14.
Effect of different strategies for excluding duplicate cultures on the correlation between hospital resistance rates and antibiotic consumption.
J Antimicrob Chemother
; 79(4): 774-778, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38334363
15.
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
J Antimicrob Chemother
; 79(2): 453-461, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169441
16.
Risk factors and outcome associated with the acquisition of MDR linezolid-resistant Enterococcus faecium: a report from tertiary care centre.
Eur J Clin Microbiol Infect Dis
; 43(4): 767-775, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372832
17.
Carbapenem or new ß-lactam-ß-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice.
Eur J Clin Microbiol Infect Dis
; 43(5): 1017-1023, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457097
18.
Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
Eur J Clin Microbiol Infect Dis
; 43(5): 875-884, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443737
19.
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.
Eur J Clin Microbiol Infect Dis
; 43(6): 1149-1160, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634975
20.
Real-time, random-access organ screening for carbapenem-resistant organisms (CRO) reduces CRO-associated, donor-derived infection mortality in lung transplant recipients.
Infection
; 52(2): 403-412, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651077